Attentional performance may help to identify duloxetine responders in chronic pain fibromyalgia patients

European Journal of Pain (United Kingdom)

Volumn 21, Issue 6, 2017, Pages 977-986

  Schmidt, G ^a   Alvarenga, R ^a   Manhaes A ^b   Schmidt, S ^a,b,c  

^a FEDERAL UNIVERSITY OF THE STATE OF RIO DE JANEIRO   (Brazil)

^b STATE UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^c FEDERAL UNIVERSITY OF JUIZ DE FORA   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

DULOXETINE;

ADULT; AGED; ARTICLE; ATTENTION DEFICIT DISORDER; ATTENTION TEST; CHRONIC PAIN; DEPRESSION; DORSOLATERAL PREFRONTAL CORTEX; DRUG RESPONSE; FEMALE; FIBROMYALGIA; HUMAN; MAJOR CLINICAL STUDY; MALE; MENTAL PERFORMANCE; NOCICEPTION; PAIN INTENSITY; POSTERIOR PARIETAL CORTEX; PREDICTIVE VALUE; PRIORITY JOURNAL; SENSITIZATION; VISUAL ATTENTION; ATTENTION; MIDDLE AGED; NEUROPSYCHOLOGICAL TEST; PAIN MEASUREMENT; PHYSIOLOGY; PSYCHOLOGY; TREATMENT OUTCOME;

ADULT; AGED; ATTENTION; CHRONIC PAIN; DULOXETINE HYDROCHLORIDE; FEMALE; FIBROMYALGIA; HUMANS; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; PAIN MEASUREMENT; TREATMENT OUTCOME;

EID: 85011592547     PISSN: 10903801     EISSN: 15322149     Source Type: Journal    
DOI: 10.1002/ejp.997     Document Type: Article

References (34)

1. Ackerman, J., Llorenta, M., Black, M., Ackerman, C., Mayes, L., Nair, P. (2008). The effect of prenatal drug exposure a care giving context on children′s performance on a task of sustained visual attention. J Dev Behav Pediatr 29, 467–474.
2. Acuna, C. (2008). Duloxetine for the treatment of fibromyalgia. Drugs Today (Barc) 44, 725–734.
3. ™) (Washington, DC: American Psychiatric Association).
4. Apkarian, A., Sosa, Y., Sonty, S., Levy, R., Harden, R., Parrish, T., Gitelman, D. (2004). Chronic back pain is associated with decreased prefrontal and thalamic gray matter density. J Neurosci 24, 10410–10415.
5. Arnold, L., Clauw, D., McCarberg, B. (2011). Improving the recognition and diagnosis of fibromyalgia. Mayo Clin Proc 86, 457–464.
6. Baliki, M., Chialvo, D., Geha, P., Levy, R., Harden, R., Parrish, T., Apkarian, A. (2006). Chronic pain and the emotional brain: Specific brain activity associated with spontaneous fluctuations of intensity of chronic back pain. J Neurosci 26, 12165–12173.
7. Baliki, M., Geha, P., Apkarian, A., Chial, D. (2008). Beyond feeling: Chronic pain hurts the brain, disrupting the default-mode networks dynamics. J Neurosci 28, 1398–1406.
8. Benjamini, Y., Hochberg, Y. (1995). Controlling the false discovery rate: A practical and powerful approach to multiple testing. J R Stat Soc Series B Stat Methodol 57, 289–300.
9. Cagnie, B., Coppieters, I., Denecker, S., Six, J., Danneels, L., Meeus, M. (2014). Central sensitization in fibromyalgia? A systematic review on structural and functional brain MRI. Semin Arthritis Rheum 44, 68–75.
10. Conners, C., Epstein, J., Angold, A., Klaric, J. (2003). Continuous performance test performance in a normative epidemiological sample. J Abnorm Child Psychol 31, 555–558.
11. DuPal, G., Anastopoulos, A., Shelton, T., Guevremont, D., Metevia, L. (1992). Multimethod assessment of attention deficit hyperactivity disorder: The diagnostic utility of clinic-based tests. J Clin Child Psychol 21, 394–402.
12. Egeland, J., Kovalik-Gran, I. (2010). Measuring several aspects of attention in one test: The factor structure of Conner's continuous performance test. J Atten Disord 13, 339–346.
13. Häuser, W., Petzke, F., Sommer, C. (2010). Comparative efficacy and harms of duloxetine, milnacipran, and pregabalin in fibromyalgia syndrome. J Pain 11, 505–521.
14. Ikeda, H., Stark, J., Fischer, H., Wagner, M., Drdla, R., Jäger, T., Sandkuhler, J. (2006). Synaptic amplifier of inflammatory pain in the spinal dorsal horn. Science 312, 1659–1662.
15. International Association for the Study of Pain (1986). Classification of chronic pain. Pain 24, S1.
16. Ogundele, M., Ayyash, H., Banerjee, S. (2011). Role of computerised continuous performance task tests in ADHD. Prog Neurol Psychiatry 15, 8–13.
17. Petersen, S., Posner, M. (2012). The attention system of the human brain: 20 years after. Annu Rev Neurosci 35, 73–89.
18. Price, D., Staud, R. (2005). Neurobiology of Fibromyalgia Syndrome. Rheumatol Suppl 5, 22–28.
19. Pujol, J., Macià, D., Garcia-Fontanals, A., Blanco-Hinojo, L., López-Solà, M., Garcia-Blanco, S., Poca-Dias, V., Harrison, J., Contreas-Rodriguez, O., Monfort, J., Garcia-Fructuoso, F., Deus, J. (2014). The contribution of sensory system functional connectivity reduction to clinical pain in fibromyalgia. Pain 155, 1492–1503.
20. Riccio, C., Reynolds, C., Lowe, P., Moore, J. (2002). The continuous performance test: A window on the neural substrates for attention. Arch Clin Neuropsychol 17, 235–272.
21. Roca, M., Monzon, S., Vives, M., Lopez-Navarro, E., Garcia-Toro, M., Vicens, C., Garcia-Campayo, J., Harrison, J., Gili, M. (2015). Cognitive function after clinical remission in patients with melancholic and non-melancholic depression: A 6 month follow-up study. J Affect Disord 171, 85–92.
22. Rock, P., Roiser, J., Riedel, W., Blackwell, D. (2014). Cognitive impairment in depression: A systematic review and meta-analysis. Psychol Med 44, 2029–2040.
23. Schmidt, S. and Manhães, A. (2005). Teste computadorizado da atenção visual (TCA Vis) (Rio de Janeiro: NeuroCog).
24. Schmidt, S., Correa, P., Tolentino, J., Manhães, A., Felix, R., Azevedo, J., Barbirato, G., Mendes, M., Boechat, Y., Cabral, H., Schmidt, G., Dohmann, H., Mesquita, C. (2008). Value of combining activated brain FDG-PET and cardiac MIBG for the differential diagnosis of dementia. Clin Nucl Med 33, 398–401.
25. Schmidt-Wilcke, T., Ichesco, E., Hampson, J., Kairys, A., Peltier, S., Harte, S., Clauw, D. and Harris, R. (2014a). Resting state connectivity correlates with drug and placebo response in fibromyalgia patients. NeuroImage: Clinical 6, 252–261.
26. Schmidt-Wilcke, T., Kairys, A., Ichesco, E., Fernandez-Sanchez, M., Barjola, P., Heitzeg, M., Harris, R., Clauw, D., Glass, J., Williams, D. (2014b). Changes in clinical pain in fibromyalgia patients correlate with changes in brain activation in the cingulate cortex in a response inhibition task. Pain Med 15, 1346–1358.
27. Soreni, N., Crosbie, J., Ickowicz, A., Schachar, R. (2009). Stop signal and Conners' continuous performance tasks: Test–retest reliability of two inhibition measures in ADHD children. J Atten Disord 13, 137–143.
28. Staud, R. (2002). Evidence of involvement of central neural mechanisms in generating fibromyalgia pain. Curr Rheumatol Rep 4, 299–305.
29. Tinius, T. (2003). The integrated visual and auditory continuous performance test as a neuropsychological measure. Arch Clin Neuropsychol 18, 439–454.
30. Uno, M., Abe, J., Sawai, C., Sakaue, U., Nishitani, A., Yasuda, Y., Tsuzuki, K., Takano, T., Ohno, M., Maruyama, T., Takeuchi, Y. (2006). Effect of additional auditory and visual stimuli on continuous performance test (noise-generated CPT) in AD/HD children – usefulness of noise-generated CPT. Brain Dev 28, 162–169.
31. Wolfe, F., Smythe, H., Yunus, M., Bennett, R., Bombardier, C., Goldenberg, D., Tugwell, P., Campbell, S., Abeles, M., Clark, P., Fam, A., Farber, S., Fiechtner, J., Franklin, M., Gatter, R., Hamaty, D., Lessard, L., Lichtbroun, A., Masi, A., Mccain, G., Reynolds, J., Romano, T., Russel, I., Sheon, R. (1990). The American College of Rheumatology 1990 Criteria for the Classification of Fibromyalgia. Report of the Multicenter Criteria Committee. Arthritis Rheum 33, 160–172.
32. Wolfe, F., Clauw, D., Fitzcharles, M., Goldenberg, D., Katz, R., Mease, P., Russell, A., Russel, I., Winfield, J., Yunus, M. (2010). The American College of Rheumatology preliminary diagnostic criteria for fibromyalgia and measurement of symptom severity. Arthritis Care Res 62, 600–610.
33. Wolfe, F., Clauw, D., Fitzcharles, M., Goldenberg, D., Häuser, W., Katz, R., Mease, P., Russell, A., Russel, I., Winfield, J. (2011). Fibromyalgia criteria and severity scales for clinical and epidemiological studies: A modification of the ACR Preliminary Diagnostic Criteria for Fibromyalgia. J Rheumatol 38, 1113–1122.
34. Wright, C., Mist, S., Ross, R., Jones, K. (2010). Duloxetine for the treatment of fibromyalgia. Expert Rev Clin Immunol 6, 745–756.